SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

10 Feb 2026 Evaluate
The sales declined to Rs. 1142.42 millions for the December 2025 quarter as compared to Rs. 1462.52 millions during the corresponding quarter last year.Net Profit of the company move down -66.40% to Rs. 117.59  millions from Rs. 349.98 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 268.94 millions from 523.58 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1142.42 1462.52 -21.89 3403.76 3084.94 10.33 4305.32 3070.90 40.20
Other Income 34.31 22.20 54.55 178.00 77.95 128.35 116.78 81.54 43.22
PBIDT 268.94 523.58 -48.63 867.60 752.35 15.32 1117.93 451.40 147.66
Interest 30.26 40.93 -26.07 87.19 112.09 -22.21 141.99 170.52 -16.73
PBDT 217.63 482.65 -54.91 759.36 640.26 18.60 975.94 190.88 411.28
Depreciation 51.73 58.20 -11.12 158.54 175.75 -9.79 231.73 236.96 -2.21
PBT 165.90 424.45 -60.91 600.82 464.51 29.34 744.21 -46.08 -1715.04
TAX 48.31 74.47 -35.13 173.70 81.47 113.21 68.05 141.36 -51.86
Deferred Tax 17.19 0.00 0.00 65.38 0.00 0.00 -63.17 0.00 0.00
PAT 117.59 349.98 -66.40 427.12 383.04 11.51 676.16 -187.44 -460.73
Equity 144.36 145.77 -0.97 145.84 145.77 0.05 145.84 144.37 1.02
PBIDTM(%) 23.54 35.80 -34.24 25.49 24.39 4.52 25.97 14.70 76.65

Fermenta Biotech Share Price

314.55 3.00 (0.96%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×